Old Mission Capital
BIO icon

Old Mission Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Old Mission Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-800
Closed -$280K – 491
2020
Q1 		$280K Buy
+800
New +$294K 0.02% 301

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Old Mission Capital's BIO Position: Q2 2020 in Review

Old Mission Capital sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2020, closing a stake of 800 shares — an estimated $280K sold.

Old Mission Capital first reported a position in BIO in Q1 2020 and held it in 1 quarter. The position peaked at $280K in Q1 2020. 470 funds tracked by Wall St. Rank hold BIO as of Q2 2020.

  • Old Mission Capital reported no remaining Bio-Rad Laboratories Class A position as of Q2 2020 after selling out during the quarter.
  • Old Mission Capital sold 800 Bio-Rad Laboratories Class A shares in Q2 2020, an estimated $280K.
  • Old Mission Capital first reported a position in Bio-Rad Laboratories Class A in Q1 2020 and held it in 1 quarter.
  • Old Mission Capital's Bio-Rad Laboratories Class A position peaked at $280K in Q1 2020.
  • 470 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2020.

Based on Old Mission Capital's 13F filing for Q2 2020, filed 12 Aug 2020.